Economic burden of multiple sclerosis in the United States: A systematic literature review
Author:
Affiliation:
1. Sandoz International GmbH, Holzkirchen, Germany.
2. Novartis Healthcare Pvt. Ltd., Hyderabad, India.
3. Sandoz Pvt. Ltd., Hyderabad, India.
4. Sandoz Inc., Princeton, NJ.
5. College of Pharmacy, Oregon State University, Corvallis.
Publisher
Academy of Managed Care Pharmacy
Subject
Health Policy,Pharmaceutical Science,Pharmacy
Reference86 articles.
1. Apparent changes in the epidemiology and severity of multiple sclerosis
2. Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
3. The cost burden of multiple sclerosis in the United States: a systematic review of the literature
4. Multiple sclerosis: Pathology, diagnosis and treatments
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review;PharmacoEconomics;2024-08-24
2. The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review;Cureus;2024-08-19
3. Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project;Neurology and Therapy;2024-08-02
4. Prospects for microbiome modulation in autoimmune diseases: a literature review;Sechenov Medical Journal;2024-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3